Sutro Biopharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Sutro Biopharma Inc.
- Former names
- Fundamental Applied Biology Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- South SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- STRO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001382101
- EIN
- 45-2441988
Board of directors
-
Connie Matsui · DirectorSince 2023
-
Daniel H. Petree · DirectorSince 2023
-
Heidi Hunter · DirectorSince 2023
-
James P. Panek · DirectorSince 2023
-
Jane Chung · Director · Chief Executive OfficerSince 2025
-
John Gordon Freund · DirectorSince 2023
-
Jon Marc Wigginton · DirectorSince 2023
-
Joseph M. Lobacki · DirectorSince 2023
-
Michael Dybbs · DirectorSince 2023
-
Sukhi Jagpal · DirectorSince 2024
-
William J. Newell · Director · CEOSince 2023
Chief executives
William J. Newell
· CEO
Dates unknown
Jane Chung
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.5%
-
85.7%
-
100.0%
Board connections
3 of this board's directors also sit on 7 other boards.
- via Connie Matsui
- via John Gordon Freund
- via Connie Matsui
- via Michael Dybbs
- via Michael Dybbs
- via John Gordon Freund
- via Michael Dybbs
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $89,601
- 5 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Gerber Hans-Peter Officer (CHIEF SCIENTIFIC OFFICER) | Option exercise | +3,750 | — | — |
| Sep 18, 2026 | Gerber Hans-Peter Officer (CHIEF SCIENTIFIC OFFICER) | Shares withheld for tax | −1,345 | $15.34 | $20,632 |
| Jun 2, 2026 | Chow Gregory K. Officer (CFO) | Option exercise | +2,500 | — | — |
| Mar 4, 2026 | Pauling David Officer (Chief Admin. Ofcr. & GC) | Option exercise | +675 | — | — |
| Mar 4, 2026 | Jane Chung Director, Officer (Chief Executive Officer) | Option exercise | +788 | — | — |
| Mar 4, 2026 | Pauling David Officer (Chief Admin. Ofcr. & GC) | Shares withheld for tax | −277 | $21.31 | $5,903 |
| Mar 4, 2026 | Jane Chung Director, Officer (Chief Executive Officer) | Shares withheld for tax | −282 | $21.31 | $6,009 |
| Mar 2, 2026 | Gerber Hans-Peter Officer (CHIEF SCIENTIFIC OFFICER) | Option exercise | +2,843 | — | — |
| Mar 2, 2026 | Pauling David Officer (Chief Admin. Ofcr. & GC) | Option exercise | +2,356 | — | — |
| Mar 2, 2026 | Gerber Hans-Peter Officer (CHIEF SCIENTIFIC OFFICER) | Shares withheld for tax | −1,170 | $20.55 | $24,044 |
| Mar 2, 2026 | Jane Chung Director, Officer (Chief Executive Officer) | Option exercise | +7,750 | — | — |
| Mar 2, 2026 | Pauling David Officer (Chief Admin. Ofcr. & GC) | Shares withheld for tax | −970 | $20.55 | $19,934 |
| Mar 2, 2026 | Jane Chung Director, Officer (Chief Executive Officer) | Shares withheld for tax | −2,779 | $20.55 | $57,108 |
| Mar 1, 2026 | Pauling David Officer (Chief Admin. Ofcr. & GC) | Option exercise | +500 | — | — |
| Mar 1, 2026 | Gerber Hans-Peter Officer (CHIEF SCIENTIFIC OFFICER) | Option exercise | +1,125 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.